AU Stock MarketDetailed Quotes

HPC The Hydration Pharmaceuticals Co Ltd

Watchlist
  • 0.009
  • 0.0000.00%
20min DelayTrading Jul 3 12:49 AET
2.74MMarket Cap-152P/E (Static)

The Hydration Pharmaceuticals Co Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 30, 2023
(Q4)Dec 30, 2023
(FY)Dec 30, 2022
(Q4)Dec 30, 2022
(FY)Dec 30, 2021
Assets
Current assets
Cash, cash equivalents and short term investments
-60.75%1.84M
-60.75%1.84M
-56.07%4.69M
--4.69M
--10.67M
-Cash and cash equivalents
-60.75%1.84M
-60.75%1.84M
-56.07%4.69M
--4.69M
--10.67M
-Accounts receivable
35.99%1.78M
35.99%1.78M
28.06%1.31M
--1.31M
--1.02M
-Notes receivable
----
----
--22.05K
--22.05K
----
-Other receivables
7.06%2M
7.06%2M
25.77%1.87M
--1.87M
--1.49M
Total current assets
-35.60%6.69M
-35.60%6.69M
-32.11%10.39M
--10.39M
--15.31M
Non current assets
-Long term equity investment
4.88%3.89M
4.88%3.89M
--3.71M
--3.71M
----
Regulatory assets
33.85%1.75M
33.85%1.75M
29.02%1.31M
--1.31M
--1.01M
Liabilities
Current liabilities
-accounts payable
133.63%1.06M
133.63%1.06M
-20.34%453.47K
--453.47K
--569.24K
-Total tax payable
4.88%3.92M
4.88%3.92M
18,081.01%3.73M
--3.73M
--20.54K
Current provisions
-80.19%69.23K
-80.19%69.23K
--349.47K
--349.47K
----
Current liabilities
17.12%3.13M
17.12%3.13M
29.99%2.68M
--2.68M
--2.06M
Non current liabilities
Long term provisions
4.88%3.89M
4.88%3.89M
--3.71M
--3.71M
----
Employee benefits
----
----
--22.05K
--22.05K
----
Regulatory liabilities
-202.65%-38.99K
-202.65%-38.99K
0.00%-12.88K
---12.88K
---12.88K
Total non current liabilities
9.99%7.05M
9.99%7.05M
208.33%6.41M
--6.41M
--2.08M
Shareholders'equity
Share capital
7.42%39.33M
7.42%39.33M
0.56%36.61M
--36.61M
--36.41M
-common stock
7.42%39.33M
7.42%39.33M
0.56%36.61M
--36.61M
--36.41M
Gains losses not affecting retained earnings
44.68%3.39M
44.68%3.39M
97.53%2.34M
--2.34M
--1.19M
Total equity
-35.60%6.69M
-35.60%6.69M
-32.11%10.39M
--10.39M
--15.31M
(FY)Dec 30, 2023(Q4)Dec 30, 2023(FY)Dec 30, 2022(Q4)Dec 30, 2022(FY)Dec 30, 2021
Assets
Current assets
Cash, cash equivalents and short term investments -60.75%1.84M-60.75%1.84M-56.07%4.69M--4.69M--10.67M
-Cash and cash equivalents -60.75%1.84M-60.75%1.84M-56.07%4.69M--4.69M--10.67M
-Accounts receivable 35.99%1.78M35.99%1.78M28.06%1.31M--1.31M--1.02M
-Notes receivable ----------22.05K--22.05K----
-Other receivables 7.06%2M7.06%2M25.77%1.87M--1.87M--1.49M
Total current assets -35.60%6.69M-35.60%6.69M-32.11%10.39M--10.39M--15.31M
Non current assets
-Long term equity investment 4.88%3.89M4.88%3.89M--3.71M--3.71M----
Regulatory assets 33.85%1.75M33.85%1.75M29.02%1.31M--1.31M--1.01M
Liabilities
Current liabilities
-accounts payable 133.63%1.06M133.63%1.06M-20.34%453.47K--453.47K--569.24K
-Total tax payable 4.88%3.92M4.88%3.92M18,081.01%3.73M--3.73M--20.54K
Current provisions -80.19%69.23K-80.19%69.23K--349.47K--349.47K----
Current liabilities 17.12%3.13M17.12%3.13M29.99%2.68M--2.68M--2.06M
Non current liabilities
Long term provisions 4.88%3.89M4.88%3.89M--3.71M--3.71M----
Employee benefits ----------22.05K--22.05K----
Regulatory liabilities -202.65%-38.99K-202.65%-38.99K0.00%-12.88K---12.88K---12.88K
Total non current liabilities 9.99%7.05M9.99%7.05M208.33%6.41M--6.41M--2.08M
Shareholders'equity
Share capital 7.42%39.33M7.42%39.33M0.56%36.61M--36.61M--36.41M
-common stock 7.42%39.33M7.42%39.33M0.56%36.61M--36.61M--36.41M
Gains losses not affecting retained earnings 44.68%3.39M44.68%3.39M97.53%2.34M--2.34M--1.19M
Total equity -35.60%6.69M-35.60%6.69M-32.11%10.39M--10.39M--15.31M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg